- Home
- CTNT vs VRAX Comparison
CTNT vs VRAX Comparison
Compare CTNT & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNT
- VRAX
- Stock Information
- Founded
- CTNT 2016
- VRAX 2013
- Country
- CTNT United States
- VRAX United Kingdom
- Employees
- CTNT N/A
- VRAX N/A
- Industry
- CTNT
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CTNT
- VRAX Health Care
- Exchange
- CTNT Nasdaq
- VRAX Nasdaq
- Market Cap
- CTNT 6.5M
- VRAX 5.9M
- IPO Year
- CTNT 2023
- VRAX 2022
- Fundamental
- Price
- CTNT $1.37
- VRAX $1.09
- Analyst Decision
- CTNT Hold
- VRAX Strong Buy
- Analyst Count
- CTNT 1
- VRAX 1
- Target Price
- CTNT N/A
- VRAX $3.00
- AVG Volume (30 Days)
- CTNT 15.2K
- VRAX 125.6K
- Earning Date
- CTNT 05-12-2025
- VRAX 02-05-2025
- Dividend Yield
- CTNT N/A
- VRAX N/A
- EPS Growth
- CTNT N/A
- VRAX N/A
- EPS
- CTNT N/A
- VRAX N/A
- Revenue
- CTNT $455,805.00
- VRAX $84,872.00
- Revenue This Year
- CTNT $258.05
- VRAX $5,169.18
- Revenue Next Year
- CTNT N/A
- VRAX $66.97
- P/E Ratio
- CTNT N/A
- VRAX N/A
- Revenue Growth
- CTNT N/A
- VRAX 7.03
- 52 Week Low
- CTNT $1.25
- VRAX $0.60
- 52 Week High
- CTNT $236.16
- VRAX $9.00
- Technical
- Relative Strength Index (RSI)
- CTNT 27.79
- VRAX 32.51
- Support Level
- CTNT $1.25
- VRAX $1.10
- Resistance Level
- CTNT $1.93
- VRAX $1.35
- Average True Range (ATR)
- CTNT 0.13
- VRAX 0.11
- MACD
- CTNT -0.01
- VRAX 0.00
- Stochastic Oscillator
- CTNT 17.70
- VRAX 6.77
About CTNT Cheetah Net Supply Chain Service Inc.
Cheetah Net Supply Chain Service Inc is a supplier of parallel-import vehicles sourced in the U.S. to be sold in the China market. The parallel-import vehicles refer to those purchased by dealers directly from overseas markets and imported for sale through channels other than brand manufacturers' official distribution systems. The company purchases automobiles, luxury brands such as Mercedes, BMW, Porsche, Lexus, and Bentley, from the U.S. market and resells them to customers, including both U.S. and PRC parallel-import car dealers. The company derives profits from the price difference between buying and selling prices for parallel-import vehicles.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.